Amarin v. FDA: Predicting the Future of Off-Label Promotion

If folks in your marketing department seem unduly cheerful despite the end of summer, they may be experiencing a case of Amarin-induced euphoria. But, while your colleagues are feeling euphoric, you, as a compliance professional, may now feel acute off-label promotion anxiety. What may the future hold in a post-Amarin world?
[Read more…]

Cannabis Packaging and Labeling: Challenges with Intrastate Compliance

Cannabis Today
2014 was a monumental year for the US legal cannabis market. 25 states and Washington D.C. now have some measure of medical or adult-use legislation, creating a market that is estimated to grow to over $10BN by 2018 (Arcview Market Research, 2014).
[Read more…]

It’s Not Fair! Combating Competitors’ Dishonest Marketing Tactics

What do you do when your competitor doesn’t play by the rules?
As the “information revolution” flourishes and internet marketing for over-the-counter medical products proliferates, some marketers profit by claiming unapproved therapeutic benefits for products, while manufacturers of approved products with proven benefits suffer. In this dynamic, interactive and free-flowing information environment, new tools are emerging to allow manufacturers to police the content of competitors’ marketing.
[Read more…]